See the DrugPatentWatch profile for lurbinectedin

Lurbinectedin, a medication used in cancer treatment, does not have specific contraindications listed with anticoagulants based on the sources provided. The drug patent information from Drug Patent Watch [1] and the clinical trial details from the National Cancer Institute [2] do not mention any specific interactions or contraindications between lurbinectedin and anticoagulants. Additionally, a review article on lurbinectedin in the National Center for Biotechnology Information [3] does not highlight any concerns regarding the concurrent use of anticoagulants with lurbinectedin. However, it is always advisable to consult with a healthcare provider or pharmacist before combining medications to ensure safety and effectiveness.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN
[2] https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2020-09844
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062662/